The excessive weight gain further fuels the disease by worsening insulin resistance, dyslipidemia, hypertension, and pancreatic a-cell failure, resulting in a downward spiral [2]
Update the plan as rules change
Weight management presents a particular challenge, as many women with PCOS experience difficulty losing weight due to metabolic abnormalities
Risk factor screening and prediction modeling of gastrointestinal adverse reactions caused by GLP-1RAs
Semaglutide GLP-1 is an innovative medication originally developed for the treatment of type 2 diabetes and is now often used as an anti-obesity medication for long-term weight management
Physiological assessments indicated early reductions in stomatal conductance and photochemical efficiency, partially compensated by increased non-photochemical quenching and preserved PSII integrity